IL2RA Variants in Multiple Sclerosis and Type 1 Diabetes
Author Information
Author(s): Lisa M. Maier, Christopher E. Lowe, Jason Cooper, Kate Downes, David E. Anderson, Christopher Severson, Pamela M. Clark, Brian Healy, Neil Walker, Cristin Aubin, Jorge R. Oksenberg, Stephen L. Hauser, Alistair Compston, Stephen Sawcer, Philip L. De Jager, Linda S. Wicker, John A. Todd, David A. Hafler
Primary Institution: Brigham and Women's Hospital and Harvard Medical School
Hypothesis
Is the autoimmunity risk at IL2RA due to distinct or shared alleles?
Conclusion
The study found allelic heterogeneity at the IL2RA region between multiple sclerosis and type 1 diabetes, with some alleles conferring susceptibility to one disease while providing protection against the other.
Supporting Evidence
- The study identified distinct alleles associated with susceptibility to MS and T1D.
- Multiple variants were found to independently correlate with sIL-2RA levels.
- The findings emphasize the need for caution when interpreting results from complex genetic regions.
Takeaway
This study looked at genes related to two diseases, multiple sclerosis and type 1 diabetes, and found that some gene variations can make you more likely to get one disease but help protect you from the other.
Methodology
A genetic association study of three IL2RA variants was performed in a collection of healthy controls, MS, and T1D subjects.
Potential Biases
Potential bias due to self-reported ethnicity and the specific populations studied.
Limitations
The study's findings may not be generalizable beyond the populations studied, and the statistical power for some SNPs was low.
Participant Demographics
Participants were primarily self-reported white individuals.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% confidence interval (0.74–0.86)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website